We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

72 hedge funds and large institutions have $265M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 26

11% less funds holding

Funds holding: 81 → 72 (-9)

32% less capital invested

Capital invested by funds: $392M → $265M (-$127M)

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

75% less call options, than puts

Call options by funds: $63K | Put options by funds: $254K

Holders
72
Holders Change
-9
Holders Change %
-11.11%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
24
Reduced
26
Closed
17
Calls
$63K
Puts
$254K
Net Calls
-$191K
Net Calls Change
-$191K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$9.88M
2
JP Morgan Chase
JP Morgan Chase
New York
+$5.59M
3
Artisan Partners
Artisan Partners
Wisconsin
+$4.17M
4
CC
Casdin Capital
New York
+$1.14M
5
Millennium Management
Millennium Management
New York
+$739K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.41M
2
Citadel Advisors
Citadel Advisors
Florida
-$6.89M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.17M
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.05M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
BL
26
Bleichroeder LP
New York
$1.03M +$645K +12,480 +100%
Bank of America
27
Bank of America
North Carolina
$857K +$291K +5,629 +37%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$725K +$23.3K +450 +3%
State Street
29
State Street
Massachusetts
$705K -$155K -3,006 -15%
WP
30
Woodline Partners
California
$686K -$648K -12,534 -43%
MOACM
31
Mutual of America Capital Management
New York
$684K +$46.8K +905 +6%
N
32
Nuveen
North Carolina
$402K – – –
Victory Capital Management
33
Victory Capital Management
Texas
$374K -$197K -3,812 -29%
Ameriprise
34
Ameriprise
Minnesota
$342K +$70K +1,355 +19%
Goldman Sachs
35
Goldman Sachs
New York
$240K -$587K -11,361 -66%
TD Asset Management
36
TD Asset Management
Ontario, Canada
$237K -$173K -3,354 -37%
TI
37
Trexquant Investment
Connecticut
$201K -$36.8K -711 -13%
VEA
38
Virtus ETF Advisers
New York
$166K -$28.4K -550 -12%
Renaissance Technologies
39
Renaissance Technologies
New York
$163K -$3.05M -59,086 -94%
Northern Trust
40
Northern Trust
Illinois
$149K +$258 +5 +0.1%
SEI Investments
41
SEI Investments
Pennsylvania
$147K -$13K -251 -7%
Geode Capital Management
42
Geode Capital Management
Massachusetts
$139K +$17.3K +334 +11%
FA
43
Forefront Analytics
Pennsylvania
$123K +$58.1K +1,124 +59%
Legal & General Group
44
Legal & General Group
United Kingdom
$105K – – –
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$90K +$113K +2,186 New
WCM
46
Weld Capital Management
New York
$86K +$14.6K +282 +16%
Mitsubishi UFJ Asset Management
47
Mitsubishi UFJ Asset Management
Japan
$85K -$4.65K -90 -4%
Citadel Advisors
48
Citadel Advisors
Florida
$80K -$6.89M -133,363 -99%
CAN
49
Cetera Advisor Networks
California
$76K +$19.1K +370 +25%
HF
50
HRT Financial
New York
$71K +$89.7K +1,736 New
1
2
3 4

ORTX Hedge Fund Activity: Q3 2020 in Review

72 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q3 2020, worth a combined $265M — down 32% from $392M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ORTX and 9 opened new positions — a net loss of 8 holders — while 26 trimmed existing stakes and 24 added.

The largest buyer was RA Capital Management, adding an estimated $9.88M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.41M.

  • 72 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q3 2020, down from 81 in Q2 2020.
  • Funds reported $265M of Orchard Therapeutics plc American Depositary Shares stock for Q3 2020, down 32% quarter-over-quarter.
  • 9 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q3 2020 and 17 closed out, a net change of -8 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q3 2020 was RA Capital Management, an estimated $9.88M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q3 2020 was T. Rowe Price Associates, an estimated $9.41M sold.

Based on aggregated 13F filings for Q3 2020.